XML 17 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Dec. 31, 2016
Dec. 31, 2015
Cash and Cash Equivalents [Line Items]            
Document Period End Date     Sep. 30, 2017      
Cash, Cash Equivalents and Restricted Cash     $ 823,207 $ 766,962 $ 781,283 $ 673,173
Cash flows from operating activities:            
Net income $ 75,913 $ 71,545 212,125 199,865    
Adjustments to reconcile net income to net cash provided by operating activities:            
Amortization 21,435 21,805 64,402 65,025    
Depreciation 5,489 5,195 17,242 15,867    
Non-cash stock-based compensation     22,362 11,593    
Change in estimated acquisition earn-out payables (1,308) 3,610 8,309 6,846    
Deferred income taxes     23,941 20,081    
Amortization of debt discount     119 118    
Deferred Finance Costs, Own-share Lending Arrangement, Issuance Costs, Amortization Expense     1,309 1,207    
Accretion (Amortization) of Discounts and Premiums, Investments     20 36    
Income tax benefit from exercise of shares from the stock benefit plans     0 (7,213)    
Payments On Acquisition Earn Outs In Excess Of Original Estimated Payables     (13,800) (3,683)    
Net loss/(gain) on sales of investments, fixed assets and customer accounts     (1,739) (2,860)    
Changes in operating assets and liabilities, net of effect from acquisitions and divestitures:            
Premiums, commissions and fees receivable decrease (increase)     (23,350) (31,324)    
Reinsurance recoverables decrease (increase)     (2,082,203) (300,036)    
Prepaid reinsurance premiums decrease     (23,585) (24,324)    
Other assets (increase)     (5,314) 1,231    
Premiums payable to insurance companies decrease     5,585 39,787    
Premium deposits and credits due customers increase     14,030 27,914    
Losses and loss adjustment reserve (decrease) increase     2,082,203 300,036    
Unearned premiums (decrease)     23,585 24,324    
Accounts payable increase     22,113 13,858    
Accrued expenses and other liabilities (decrease)     1,018 (22,119)    
Other liabilities (decrease)     (34,802) (17,094)    
Net cash provided by operating activities     313,570 319,135    
Cash flows from investing activities:            
Additions to fixed assets (4,049) (4,191) (12,897) (13,135)    
Payments for businesses acquired, net of cash acquired     (26,478) (113,219)    
Proceeds from sales of fixed assets and customer accounts     4,085 3,411    
Purchases of investments     (10,393) (24,332)    
Proceeds from Sale, Maturity and Collection of Investments     5,178 16,716    
Net cash used in investing activities     (40,505) (130,559)    
Cash flows from financing activities:            
Payments on acquisition earn-outs     (25,488) (23,872)    
Payments on long-term debt     (91,750) (34,375)    
Income tax benefit from exercise of shares from the stock benefit plans     0 7,213    
Issuances of common stock for employee stock benefit plans     17,387 15,959    
Repurchase Of Stock Benefit Plan Shares For Employees To Fund Tax Withholdings     (6,791) (8,395)    
Purchase of treasury stock     (57,389) (11,250)    
Settlement of accelerated share repurchase program     (7,500) 11,250    
Cash dividends paid     (56,801) (51,317)    
Net cash used in financing activities     (231,141) (94,787)    
Payments of Debt Issuance Costs     (2,809)      
Net increase in cash and cash equivalents inclusive of restricted cash     41,924 93,789    
Cash and cash equivalents inclusive of restricted cash at end of period $ 546,520 $ 488,683 $ 546,520 $ 488,683 $ 515,646 $ 443,420